UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Annals of oncology, 2018-01, Vol.29 (1), p.154-161

2018

Volltextzugriff (PDF)

Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trial

Annals of oncology, 2022-03, Vol.33 (3), p.299-309

2022

Volltextzugriff (PDF)

Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial

Osteoporosis international, 2015-06, Vol.26 (6), p.1857-1864

2015

Volltextzugriff (PDF)

NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii137

2018

Volltextzugriff (PDF)

Development and implementation of a team of robotic tractors for autonomous peat moss harvesting

Journal of field robotics, 2009-06, Vol.26 (6-7), p.549-571

2009

Volltextzugriff (PDF)

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer

Annals of oncology, 2018-04, Vol.29 (4), p.872-880

2018

Volltextzugriff (PDF)

325P Characteristics of patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer who achieved durable response in the phase III BROCADE3 study

Annals of oncology, 2020-09, Vol.31, p.S374-S374

2020

Volltextzugriff (PDF)

274O Health-related quality of life (HRQoL) changes with veliparib in patients (pts) with metastatic or locally advanced breast cancer in the phase III BROCADE 3 study

Annals of oncology, 2020-09, Vol.31, p.S348-S349

2020

Volltextzugriff (PDF)

Unsanctifying the sanctuary: challenges and opportunities with brain metastases

Neuro-oncology (Charlottesville, Va.), 2015-05, Vol.17 (5), p.639-651

2015

Volltextzugriff (PDF)

Nodal micrometastases in early stage breast cancer: two case reports

Breast cancer online, 2009-03, Vol.12 (3), Article e6

2009

Volltextzugriff (PDF)

140O Veliparib plus carboplatin-paclitaxel in patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer: Results in hormone receptor-positive and triple-negative breast cancer subgroups from the phase III BROCADE3 trial

Annals of oncology, 2020-05, Vol.31, p.S65-S65

2020

Volltextzugriff (PDF)

P3-01-16: Expression of Basal Markers in Correlation with PTEN and BRCA 1 in Triple Negative Breast Carcinomas (TN) Treated with Chemotherapy Versus PARP Inhibitors

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-01-16

2011

Volltextzugriff (PDF)

ANG1005, a novel peptide-paclitaxel conjugate crosses the BBB and shows activity in patients with recurrent CNS metastasis from breast cancer, results from a phase II clinical study

Annals of oncology, 2016-10, Vol.27, p.vi103-vi103

2016

Volltextzugriff (PDF)

LBA9Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Abstract P5-06-03: Generation and characterization of a novel invasive lobular breast carcinoma cell line WCRC-25

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-06-03

2018

Volltextzugriff (PDF)

Abstract GS3-02: PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS3-02-GS3-02

2019

Volltextzugriff (PDF)

418PDNCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

A phase 1b study of abemaciclib, an inhibitor of CDK4 and CDK6, in combination with endocrine and HER2-targeted therapies for patients with metastatic breast cancer

Annals of oncology, 2016-10, Vol.27, p.vi556-vi556

2016

Volltextzugriff (PDF)

Abstract P4-12-12: Phase 2, multicenter, single-arm study of eribulin mesylate + trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-12-12

2013

Volltextzugriff (PDF)

Abstract P1-12-01: A phase II, open-label, multi-center study of ANG1005, a novel brain-penetrant peptide-drug conjugate, in breast cancer patients with recurrent CNS metastases

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-12-01

2017

Volltextzugriff (PDF)

Abstract S2-05: Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer: A randomized, phase 2 study

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.S2-S2-05

2017

Volltextzugriff (PDF)

Abstract P4-22-02: Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V+TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-22-02

2017

Volltextzugriff (PDF)

Adjuvant Endocrine Therapy for Breast Cancer: Don't Ditch the Switch

JNCI : Journal of the National Cancer Institute, 2011-09, Vol.103 (17), p.1280-1282

2011

Volltextzugriff (PDF)

Abstract P2-15-02: Attitudes towards tissue donation for rapid autopsy among community and academic oncologists

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-15-02

2017

Volltextzugriff (PDF)

Abstract P3-05-14: A neoadjuvant window trial of endocrine response in women with invasive lobular carcinoma

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-05-14

2016

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(295)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trial

Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial

NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss

Development and implementation of a team of robotic tractors for autonomous peat moss harvesting

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer

325P Characteristics of patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer who achieved durable response in the phase III BROCADE3 study

274O Health-related quality of life (HRQoL) changes with veliparib in patients (pts) with metastatic or locally advanced breast cancer in the phase III BROCADE 3 study

Unsanctifying the sanctuary: challenges and opportunities with brain metastases

Nodal micrometastases in early stage breast cancer: two case reports

140O Veliparib plus carboplatin-paclitaxel in patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer: Results in hormone receptor-positive and triple-negative breast cancer subgroups from the phase III BROCADE3 trial

P3-01-16: Expression of Basal Markers in Correlation with PTEN and BRCA 1 in Triple Negative Breast Carcinomas (TN) Treated with Chemotherapy Versus PARP Inhibitors

ANG1005, a novel peptide-paclitaxel conjugate crosses the BBB and shows activity in patients with recurrent CNS metastasis from breast cancer, results from a phase II clinical study

LBA9Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

Abstract P5-06-03: Generation and characterization of a novel invasive lobular breast carcinoma cell line WCRC-25

Abstract GS3-02: PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib

418PDNCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss

A phase 1b study of abemaciclib, an inhibitor of CDK4 and CDK6, in combination with endocrine and HER2-targeted therapies for patients with metastatic breast cancer

Abstract P4-12-12: Phase 2, multicenter, single-arm study of eribulin mesylate + trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer

Abstract P1-12-01: A phase II, open-label, multi-center study of ANG1005, a novel brain-penetrant peptide-drug conjugate, in breast cancer patients with recurrent CNS metastases

Abstract S2-05: Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer: A randomized, phase 2 study

Abstract P4-22-02: Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V+TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer

Adjuvant Endocrine Therapy for Breast Cancer: Don't Ditch the Switch

Abstract P2-15-02: Attitudes towards tissue donation for rapid autopsy among community and academic oncologists

Abstract P3-05-14: A neoadjuvant window trial of endocrine response in women with invasive lobular carcinoma

Suchergebnisse filtern